Cancer Epidemiologic Research in Understudied Populations Webinar Series
- Upcoming Topics and Speakers
- Past Topics and Speakers
- Related Links
- EGRP Planning Committee
The Epidemiology and Genomics Research Program hosts a quarterly webinar series, Cancer Epidemiologic Research in Understudied Populations. Understudied populations are groups about which there are limited data regarding cancer risks and outcomes that can inform cancer control policies and interventions. Examples of understudied populations include racial or ethnic groups; people subject to low socio-economic factors; non-metropolitan/rural populations; sexual and gender minorities; immigrant, migrant, or refugee populations; the incarcerated; and the elderly. The purpose of this webinar series is to highlight innovative cancer epidemiology research on these populations.
Presentation topics on understudied populations in cancer epidemiologic research may include:
- Cancer and health disparities
- Transdisciplinary approaches for cancer epidemiology in understudied populations
- Novel study designs and methodology
- Etiology including but not limited to biological and behavioral mechanisms, and environmental risk factors (social and physical)
- Implementation and intervention studies
Any interested individual is invited to participate; however, pre-registration is required. Each presentation will be about 30-40 minutes in length and allow for 30 minutes of discussion. Instructions for connecting to the webinars will be sent via e-mail to individuals who register.
For more information, please visit Think Tank on Understudied Populations in Cancer Epidemiologic Research: Implications for Future Needs.
Upcoming Topics and Speakers
January 17, 2018 2:00 p.m. to 3:00 p.m. ET
Cancer Prevention and Control Research in Appalachian Kentucky
Robin Vanderpool, DrPH, CHES
Associate Professor, Department of Health Behavior & Society, University of Kentucky
Dr. Vanderpool's research interests include cancer health disparities among rural and Appalachian populations, HPV vaccination, dissemination and implementation research, the impact of cancer on employment and treatment outcomes, and cancer survivorship. Dr. Vanderpool will be discussing best practices and lessons learned from the Appalachian Center for Cancer Education, Screening, and Support (ACCESS) and the UK Rural Cancer Prevention Center (RCPC) projects.
April 11, 2018 1:00 p.m. to 2:00 p.m. ET
Cancer in Incarcerated Populations
Emily Wang, MD, MAS
Associate Professor, Yale School of Medicine
Co-founder, Transitions Clinic Network
Dr. Wang's research focuses on promoting health equity for vulnerable populations, especially individuals with a history of incarceration, through both prison and community based interventions. The Transitions Clinic Network, which she co-founded, is a consortium of 15 community health centers nationwide dedicated to caring for recently released prisoners and defining best practices for the health care of individuals leaving prison. Dr. Wang's presentation will focus on cancer in incarcerated populations.
Note: Additional speakers and topics may be added in the future.
Past Topics and Speakers
October 18, 2017 1:00 p.m. to 2:00 p.m. ET
Cancer Health Disparities and Risk Factors in Homeless Populations
Travis P. Baggett, M.D., MPH
Clinician-Investigator, Division of General Medicine, Massachusetts General Hospital; Assistant Professor of Medicine, Harvard Medical School; and Staff Physician, Boston Health Care for the Homeless Program
Dr. Baggett's research focuses on the health of homeless people, with an emphasis on addictive behaviors and their medical consequences in this population. Dr. Baggett presented on cancer and cancer risk factors in homeless populations.
June 6, 2017 1:00 p.m. to 2:00 p.m. ET
Opportunities and Challenges in Survivorship Research in Adolescents and Young Adults
Scott Baker, M.D., M.S.
Director, Pediatric Blood and Marrow Transplantation and Survivorship Programs, Fred Hutchinson Cancer Research Center
Dr. Baker's research interests include short- and long-term effects of blood and marrow transplantation, incidence, risk factors and characteristics of cardiopulmonary, metabolic, renal, endocrine and reproductive late effects and quality-of-life outcomes in long-term cancer survivors. Dr. Baker presented on cancer in adolescents and young adults, especially highlighting cancer health disparities seen in outcomes and survivorship.
November 15, 2016
Lessons Learned from the NICHD/PCORI Transgender Cohort Study
Michael Goodman, M.D., M.P.H.
Associate Professor, Department of Epidemiology
Rollins School of Public Health, Emory University
Dr. Michael Goodman's current research focuses on quality of life treatment outcomes among prostate cancer patients, comparative effectiveness of colorectal cancer screening options, and health status of transgender people. Dr. Goodman shared lessons learned from a cohort study of mortality and morbidity in transgender persons, with a special emphasis on cancer-related issues in this population. This study, supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) and the Patient-Centered Outcomes Research Institute (PCORI), is potentially the largest cohort of transgender people available to date and the first study of its kind in the United States.
- Think Tank on Understudied Populations in Cancer Epidemiologic Research: Implications for Future Needs, September 2015
EGRP Planning Committee
- Katy Brignole, M.Sc., Cancer Research Training Award Fellow, Genomic Epidemiology Branch
- Tram Kim Lam, Ph.D., M.P.H., Program Director, Environmental Epidemiology Branch
- Damali N. Martin, Ph.D., M.P.H., Program Director, Genomic Epidemiology Branch
Questions about individual webinars or the series may be submitted via e-mail to the Planning Committee at NCIUnderstudiedPops@mail.nih.gov.